-
Loading metrics
Open Access
Peer-reviewed
Research Article
Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin
-
Malcolm A. Leissring ,
* E-mail: Leissring@mayo.edu
Affiliations Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida, United States of America, Department of Molecular Therapeutics, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America, Center for Neurologic Diseases, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Enrico Malito,
Affiliation Ben-May Institute for Cancer Research, University of Chicago, Chicago, Illinois, United States of America
⨯ -
Sabrine Hedouin,
Affiliation Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida, United States of America
⨯ -
Lael Reinstatler,
Affiliation Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida, United States of America
⨯ -
Tomoko Sahara,
Affiliation Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida, United States of America
⨯ -
Samer O. Abdul-Hay,
Affiliation Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida, United States of America
⨯ -
Shakeel Choudhry,
Affiliation Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida, United States of America
⨯ -
Ghulam M. Maharvi,
Affiliation Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida, United States of America
⨯ -
Abdul H. Fauq,
Affiliation Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida, United States of America
⨯ -
Malwina Huzarska,
Affiliation Department of Molecular Therapeutics, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America
⨯ -
Philip S. May,
Affiliation Department of Molecular Therapeutics, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America
⨯ -
Sungwoon Choi,
Affiliation Laboratory for Drug Discovery in Neurodegeneration, Brigham & Women's Hospital and Harvard Medical School, Cambridge, Massachusetts, United States of America
⨯ -
Todd P. Logan,
Affiliation Center for Neurologic Diseases, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Benjamin E. Turk,
Affiliation Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯ -
Lewis C. Cantley,
Affiliation Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Marika Manolopoulou,
Affiliation Ben-May Institute for Cancer Research, University of Chicago, Chicago, Illinois, United States of America
⨯ -
Wei-Jen Tang,
Affiliation Ben-May Institute for Cancer Research, University of Chicago, Chicago, Illinois, United States of America
⨯ -
Ross L. Stein,
Affiliation Laboratory for Drug Discovery in Neurodegeneration, Brigham & Women's Hospital and Harvard Medical School, Cambridge, Massachusetts, United States of America
⨯ -
Gregory D. Cuny,
Affiliation Laboratory for Drug Discovery in Neurodegeneration, Brigham & Women's Hospital and Harvard Medical School, Cambridge, Massachusetts, United States of America
⨯ - [ ... ],
-
Dennis J. Selkoe
Affiliation Center for Neurologic Diseases, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯ - [ view all ]
- [ view less ]
Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin
- Malcolm A. Leissring,
- Enrico Malito,
- Sabrine Hedouin,
- Lael Reinstatler,
- Tomoko Sahara,
- Samer O. Abdul-Hay,
- Shakeel Choudhry,
- Ghulam M. Maharvi,
- Abdul H. Fauq,
- Malwina Huzarska
- Published: May 7, 2010
- https://doi.org/10.1371/journal.pone.0010504